Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease?

RJ Porter; Caroline Andrews; DP Brice; Scott Durum; MH McLean

doi:10.1093/ibd/izy230

Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease?

RJ Porter, Caroline Andrews, DP Brice, Scott Durum, MH McLean

Division of Immunology, Immunity to Infection and Respiratory Medicine

Research output: Contribution to journal › Article › peer-review

Original language	Undefined
Pages (from-to)	2123–2134
Number of pages	12
Journal	Inflammatory Bowel Diseases
Volume	24
Issue number	10
DOIs	https://doi.org/10.1093/ibd/izy230
Publication status	Published - Sept 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/ibd/izy230

Cite this

@article{2aff7b20a2c640e0afb61ae1d01e2f37,

title = "Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease?",

author = "RJ Porter and Caroline Andrews and DP Brice and Scott Durum and MH McLean",

year = "2018",

month = sep,

doi = "10.1093/ibd/izy230",

language = "Undefined",

volume = "24",

pages = "2123–2134",

journal = "Inflammatory Bowel Diseases",

issn = "1078-0998",